Search
You're invited to try out the new version of Value Research Online. Click here to begin: https://beta.valueresearchonline.com

Jenburkt Pharmaceuticals

Sector: Healthcare | Industry: Drugs & Pharma
R 430.75 10.65  | 2.54% -31.58% 11.52 197.69
BSE Price: Oct 22, 2019 Change R    |  % 1-Year Change P/E Market Cap (R Cr)
BSE Oct 22, 2019 430.75 10.65 2.54% 415.00 420.10 669 415.00 - 434.90
Exchange & Time Last Price      Day Change Open Prev Close Volume    1-Day Range
SUBSCRIBE TO THE FREE VALUE RESEARCH STOCK INSIGHT NEWSLETTER
6M Average Volume: 1,170 P/B: 2.55 NSE Code:
52-Week Range: R 380.15 - 678.00 Dividend Yield: 2.37% BSE Code: 524731
TTM EPS: R 37.40 Book Value: R 168.93 Face Value: R 10
Number of stocks currently recommended as 'Buy' by Value Research Stock Advisor: 38
Price Graph
  • Eris Lifesciences (BSE)
  • S&P BSE Sensex


Please wait while we are fetching data...
Our equity analyst team has sifted through hundreds of companies and selected a short list of stocks that you should invest in.
This list now has 38 stocks on it. Thousands of our members are using stagnant equity markets to buy great stocks at low prices.

Membership is currently available at a 40% to 60% discount. Learn more and become a member
Performance
  YTD 1-Month 3-Month 1-Year 3-Year 5-Year 10-Year
Jenburkt Pharma. -26.47 -1.40 -17.80 -31.58 4.39 5.57 28.91
S&P BSE Small Cap -10.31 -0.11 0.26 -4.45 -0.60 4.66 5.60
S&P BSE Healthcare -7.84 -1.42 0.06 -11.61 -7.74 -1.50 11.51
Company's return has been calculated on basis of BSE's price.
As on Oct 22, 2019
Key Ratios
Revenue Per Share (R) Earnings Per Share (R) Return on Networth (%)


Please wait
while we are fetching data...


Please wait
while we are fetching data...


Please wait
while we are fetching data...
Annual Ratios (%)
  1-Year 3-Years 5-Years
Growth
Revenue 6.95 9.43 9.98
Net Profit 15.02 22.47 21.41
EPS 15.02 23.00 21.72
Book Value 26.45 24.99 23.51
Average
Operating Margin 23.13 22.93 21.93
Net Margin 15.70 14.33 13.05
Return on Networth 28.54 28.95 29.58
Return on Investment 36.90 39.38 40.13
Interim Growth Ratios (%)
  QoQ YoY YTD
Quarterly
Revenue -40.68 -10.41 -40.68
Operating Profit -93.72 -82.39 -93.72
Net Profit -99.10 -97.70 -99.10
EPS -99.10 -97.70 -99.10
TTM
Revenue -1.97 -0.59 -1.97
Operating Profit -10.19 -23.15 -10.19
Net Profit -13.31 -24.69 -13.31
EPS -13.31 -24.06 -13.31
Peer Comparison
  Market Cap
(R Cr)
Revenue
(R Cr)
Net Profit
(R Cr)
Net Margin (%) RoE (%) Price to Book Price to Earnings
Jenburkt Pharma. 197.69 120.22 17.16 13.85 28.54 2.55 11.52
Astrazeneca Pharma India 6,030.25 771.42 69.56 8.84 20.03 18.83 86.69
Eris Lifesciences 5,850.09 1,005.70 303.64 29.29 28.96 4.74 19.27
Insider Trades
Date Person  Buy / Sell Transaction
Type
No of Shares Price
(R)   
Value
(R Lakhs)
Sep 06, 2019 BHUTA HOLDINGS PVT LTD  Buy Market 2,309 423.20 9.77
Jun 03, 2019 Ashish R Shah  Sell Market 1,974 522.15 10.31
Dec 11, 2017 Ashish R Shah  Sell Market 2,900 540.90 15.69
Jul 24, 2017 Ashish R Shah  Sell Market 3,295 502.85 16.57
May 15, 2015 Ketan H Bhuta  Sell Market 3,019 420.10 12.68
News & Announcements
Contact Information

Company: Jenburkt Pharmaceuticals Ltd.

Address: Nirmala Apartments, 93 Jayprakash Road, Andheri (West), Mumbai, Maharashtra - 400058 | Phone: 022-67603603 | Fax: 022-66943127

Email: [email protected]

Website: www.jenburkt.com

Registrar & Transfer Agent: Bigshare Services Pvt Ltd

Address: Bharat Tin Works building, 1st floor, Opp. Vasant Oasis, Andheri East Mumbai - 400 059Tel: + 91 21 626 38200Fax: +91 21 62638299(Old Address) E-2&3 , Ansa Industrial Estate,Saki Vihar Road,Saki Naka, Andheri (E),Mumbai, Bharat Tin Works Building, 1st floor, Opp. Vasant Oasis, Andheri (E) | Phone: 91-022-62638200 | Fax: 91-022-62638299

Email: [email protected]

Essential checks
Altman Z-Score
8.37
Piotroski F-Score
3
Modified C-Score
4
5-Years Price to Earnings
11.52
5-Years Price to Book
2.55
Earnings Yield
EBIT / Enterprise value
15.95%
PEG
Price / Earnings to growth ratio
0.71
Related Stocks
  Current Price   Chng %
Astrazeneca Pharma India R2,412.00 +5.87%
Caplin Point Laboratories R387.75 -2.29%
Eris Lifesciences R425.40 +0.66%
FDC R160.95 +0.03%
JB Chemicals & Pharma R359.80 -1.84%
Laurus Labs R341.70 +8.06%
Strides Pharma Science R350.75 -0.88%
Sun Pharma Adv. Research R132.60 +0.08%
Suven Life Sciences R286.65 +2.17%
Wockhardt R275.20 +3.28%
As on Oct 22, 15:59